Heron Therapeuti Stock Earnings Per Share
| HRTX Stock | USD 2.77 0.16 5.46% |
Heron Therapeuti fundamentals help investors to digest information that contributes to Heron Therapeuti's financial success or failures. It also enables traders to predict the movement of Heron Stock. The fundamental analysis module provides a way to measure Heron Therapeuti's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Heron Therapeuti stock.
Heron | Earnings Per Share |
Heron Therapeuti Company Earnings Per Share Analysis
Heron Therapeuti's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Heron Therapeuti Earnings Per Share | (0.80) X |
Most of Heron Therapeuti's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Heron Therapeuti is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Heron Earnings Per Share Driver Correlations
Understanding the fundamental principles of building solid financial models for Heron Therapeuti is extremely important. It helps to project a fair market value of Heron Stock properly, considering its historical fundamentals such as Earnings Per Share. Since Heron Therapeuti's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Heron Therapeuti's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Heron Therapeuti's interrelated accounts and indicators.
Click cells to compare fundamentals
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
| Competition |
Heron Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
According to the company disclosure, Heron Therapeuti has an Earnings Per Share of -0.8 times. This is 109.56% lower than that of the Biotechnology sector and 83.3% lower than that of the Health Care industry. The earnings per share for all United States stocks is 125.64% higher than that of the company.
Heron Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Heron Therapeuti's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Heron Therapeuti could also be used in its relative valuation, which is a method of valuing Heron Therapeuti by comparing valuation metrics of similar companies.Heron Therapeuti is currently under evaluation in earnings per share category among related companies.
Heron Fundamentals
| Return On Equity | -24.09 | ||||
| Return On Asset | -0.25 | ||||
| Profit Margin | (0.87) % | ||||
| Operating Margin | (0.28) % | ||||
| Current Valuation | 539.68 M | ||||
| Shares Outstanding | 150.33 M | ||||
| Shares Owned By Insiders | 0.93 % | ||||
| Shares Owned By Institutions | 76.04 % | ||||
| Number Of Shares Shorted | 25.55 M | ||||
| Price To Earning | (5.15) X | ||||
| Price To Book | 12.60 X | ||||
| Price To Sales | 3.44 X | ||||
| Revenue | 127.04 M | ||||
| Gross Profit | (50.51 M) | ||||
| EBITDA | (107.72 M) | ||||
| Net Income | (110.56 M) | ||||
| Cash And Equivalents | 83.54 M | ||||
| Cash Per Share | 0.81 X | ||||
| Total Debt | 179.63 M | ||||
| Debt To Equity | 6.64 % | ||||
| Current Ratio | 1.77 X | ||||
| Book Value Per Share | (0.23) X | ||||
| Cash Flow From Operations | (58.79 M) | ||||
| Short Ratio | 9.17 X | ||||
| Earnings Per Share | (0.80) X | ||||
| Price To Earnings To Growth | (0.18) X | ||||
| Target Price | 7.0 | ||||
| Number Of Employees | 126 | ||||
| Beta | 1.71 | ||||
| Market Capitalization | 440.46 M | ||||
| Total Asset | 222.51 M | ||||
| Retained Earnings | (1.91 B) | ||||
| Working Capital | 109.09 M | ||||
| Current Asset | 134.75 M | ||||
| Current Liabilities | 19.73 M | ||||
| Net Asset | 222.51 M |
About Heron Therapeuti Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Heron Therapeuti's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Heron Therapeuti using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Heron Therapeuti based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Heron Therapeuti in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Heron Therapeuti's short interest history, or implied volatility extrapolated from Heron Therapeuti options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Heron Therapeuti Piotroski F Score and Heron Therapeuti Altman Z Score analysis. For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Complementary Tools for Heron Stock analysis
When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |
Is Heron Therapeuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Heron Therapeuti. If investors know Heron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Heron Therapeuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.80) | Revenue Per Share 0.92 | Quarterly Revenue Growth 0.14 | Return On Assets (0.25) | Return On Equity (24.09) |
The market value of Heron Therapeuti is measured differently than its book value, which is the value of Heron that is recorded on the company's balance sheet. Investors also form their own opinion of Heron Therapeuti's value that differs from its market value or its book value, called intrinsic value, which is Heron Therapeuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Heron Therapeuti's market value can be influenced by many factors that don't directly affect Heron Therapeuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Heron Therapeuti's value and its price as these two are different measures arrived at by different means. Investors typically determine if Heron Therapeuti is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Heron Therapeuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.